Trends in utilization of neoadjuvant and adjuvant chemotherapy for muscle invasive bladder cancer.
Coleman McFerrinFacundo M DavaroAllison MaySyed Johar RazaSameer SiddiquiZachary HamiltonPublished in: Investigative and clinical urology (2020)
The increasing use of perioperative chemotherapy noted in prior studies has continued through 2015. Neoadjuvant chemotherapy appears to drive this increase while adjuvant chemotherapy utilization remains unchanged. Clinical and socioeconomic factors affect utilization of perioperative chemotherapy.